Order Article Reprints

Ceruti T, Frapolli R, Ghilardi C, Decio A, Dellavedova G, Tommasi S, Zucchetti M, Mangoni AA. Development of a HPLC-MS/MS Method to Assess the Pharmacokinetics and Tumour Distribution of the Dimethylarginine Dimethylaminohydrolase 1 Inhibitors ZST316 and L-257 in a Xenograft Model of Triple-Negative Breast Cancer in Mice. Molecules. 2023; 28(24):8056. https://doi.org/10.3390/molecules28248056

Ceruti, Tommaso, Roberta Frapolli, Carmen Ghilardi, Alessandra Decio, Giulia Dellavedova, Sara Tommasi, Massimo Zucchetti, and Arduino A. Mangoni. 2023. "Development of a HPLC-MS/MS Method to Assess the Pharmacokinetics and Tumour Distribution of the Dimethylarginine Dimethylaminohydrolase 1 Inhibitors ZST316 and L-257 in a Xenograft Model of Triple-Negative Breast Cancer in Mice" Molecules 28, no. 24: 8056. https://doi.org/10.3390/molecules28248056

Ceruti, T., Frapolli, R., Ghilardi, C., Decio, A., Dellavedova, G., Tommasi, S., Zucchetti, M., & Mangoni, A. A. (2023). Development of a HPLC-MS/MS Method to Assess the Pharmacokinetics and Tumour Distribution of the Dimethylarginine Dimethylaminohydrolase 1 Inhibitors ZST316 and L-257 in a Xenograft Model of Triple-Negative Breast Cancer in Mice. Molecules, 28(24), 8056. https://doi.org/10.3390/molecules28248056